120 related articles for article (PubMed ID: 36325982)
1. Design, synthesis and molecular docking and ADME studies of novel hydrazone derivatives for AChE inhibitory, BBB permeability and antioxidant effects.
Osmaniye D; Ahmad I; Sağlık BN; Levent S; Patel HM; Ozkay Y; Kaplancıklı ZA
J Biomol Struct Dyn; 2023; 41(18):9022-9038. PubMed ID: 36325982
[TBL] [Abstract][Full Text] [Related]
2. Design, Synthesis, and Evaluation of Novel 2
Haji Ali S; Osmaniye D; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408519
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, biological activities, and evaluation of molecular docking-dynamics studies of new thiosemicarbazones that may be effective against Alzheimer's disease.
Conger N; Osmaniye D; Sağlık BN; Levent S; Ozkay Y; Kaplancıklı ZA
J Mol Recognit; 2023 Dec; 36(12):e3059. PubMed ID: 37723924
[TBL] [Abstract][Full Text] [Related]
4. Design, Synthesis, In Silico Studies and In Vitro Evaluation of New Indole- and/or Donepezil-like Hybrids as Multitarget-Directed Agents for Alzheimer's Disease.
Angelova VT; Georgiev B; Pencheva T; Pajeva I; Rangelov M; Todorova N; Zheleva-Dimitrova D; Kalcheva-Yovkova E; Valkova IV; Vassilev N; Mihaylova R; Stefanova D; Petrov B; Voynikov Y; Tzankova V
Pharmaceuticals (Basel); 2023 Aug; 16(9):. PubMed ID: 37765003
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of novel chalcone derivatives and evaluation of their inhibitory activities against acetylcholinesterase.
Ceyhun İ; Karaca Ş; Osmaniye D; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100372. PubMed ID: 34893996
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, in silico and in vitro studies of hydrazide-hydrazone imine derivatives as potential cholinesterase inhibitors.
Güngör SA
Chem Biol Drug Des; 2023 Oct; 102(4):676-691. PubMed ID: 37258044
[TBL] [Abstract][Full Text] [Related]
7. Bioactive sulfonyl hydrazones with alkyl derivative: Characterization, ADME properties, molecular docking studies and investigation of inhibition on choline esterase enzymes for the diagnosis of Alzheimer's disease.
Bilen E; Özdemir Özmen Ü; Çete S; Alyar S; Yaşar A
Chem Biol Interact; 2022 Jun; 360():109956. PubMed ID: 35452634
[TBL] [Abstract][Full Text] [Related]
8. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Structure-Activity Relationships of Thiazole Analogs as Anticholinesterase Agents for Alzheimer's Disease.
Sağlık BN; Osmaniye D; Acar Çevik U; Levent S; Kaya Çavuşoğlu B; Özkay Y; Kaplancıklı ZA
Molecules; 2020 Sep; 25(18):. PubMed ID: 32962239
[TBL] [Abstract][Full Text] [Related]
10. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N
Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578
[TBL] [Abstract][Full Text] [Related]
11. New azole-derived hemiaminal ethers as promising acetylcholinesterase inhibitors: synthesis, X-ray structures,
Nisar M; Gondal HY; Cheema ZM; Yousaf S; Nadeem H
J Biomol Struct Dyn; 2023; 41(24):15535-15548. PubMed ID: 37021341
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, extra-precision docking, and molecular dynamics simulation studies of pyrrolidin-2-one derivatives as potential acetylcholinesterase inhibitors.
Gupta M; Kumar A; Prasun C; Nair MS; Kini SG; Yadav D; Nain S
J Biomol Struct Dyn; 2023; 41(13):6282-6294. PubMed ID: 35921217
[TBL] [Abstract][Full Text] [Related]
13. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.
Sadafi Kohnehshahri M; Chehardoli G; Bahiraei M; Akbarzadeh T; Ranjbar A; Rastegari A; Najafi Z
Mol Divers; 2022 Feb; 26(1):489-503. PubMed ID: 34491490
[TBL] [Abstract][Full Text] [Related]
14. N-Substituted piperidine-3-carbohydrazide-hydrazones against Alzheimer's disease: Synthesis and evaluation of cholinesterase, beta-amyloid inhibitory activity, and antioxidant capacity.
Parlar S; Sayar G; Tarikogullari AH; Karadagli SS; Alan E; Sevin G; Erciyas E; Holzgrabe U; Alptuzun V
Arch Pharm (Weinheim); 2023 Mar; 356(3):e2200519. PubMed ID: 36461719
[TBL] [Abstract][Full Text] [Related]
15. New piperidine-hydrazone derivatives: Synthesis, biological evaluations and molecular docking studies as AChE and BChE inhibitors.
Karaman N; Sıcak Y; Taşkın-Tok T; Öztürk M; Karaküçük-İyidoğan A; Dikmen M; Koçyiğit-Kaymakçıoğlu B; Oruç-Emre EE
Eur J Med Chem; 2016 Nov; 124():270-283. PubMed ID: 27592396
[TBL] [Abstract][Full Text] [Related]
16. Design, Synthesis, and Biological Evaluation of Novel Indanone Derivatives as Cholinesterase Inhibitors for Potential Use in Alzheimer's Disease.
Etemadi A; Hemmati S; Shahrivar-Gargari M; Abibiglue YT; Bavili A; Hamzeh-Mivehroud M; Dastmalchi S
Chem Biodivers; 2023 Aug; 20(8):e202300075. PubMed ID: 37458518
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, crystal structure,
Kausar N; Murtaza S; Arshad MN; Zaib Saleem RS; Asiri AM; Kausar S; Altaf AA; Tatheer A; Elnaggar AY; El-Bahy SM
RSC Adv; 2021 Dec; 12(1):154-167. PubMed ID: 35424495
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of thienopyrimidine derivatives as multifunctional agents against Alzheimer's disease.
Eissa KI; Kamel MM; Mohamed LW; Doghish AS; Alnajjar R; Al-Karmalawy AA; Kassab AE
Drug Dev Res; 2023 Aug; 84(5):937-961. PubMed ID: 37067008
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of thienopyrimidine and thienotriazine derivatives as multitarget anti-Alzheimer agents.
Eissa KI; Kamel MM; Mohamed LW; Galal MA; Kassab AE
Drug Dev Res; 2022 Sep; 83(6):1394-1407. PubMed ID: 35749685
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, biological evaluation, and molecular modeling simulations of new phthalazine-1,4-dione derivatives as anti-Alzheimer's agents.
Nuha D; Evren AE; Özkan BNS; Gundogdu-Karaburun N; Karaburun AÇ
Arch Pharm (Weinheim); 2024 Jul; ():e2400067. PubMed ID: 38967191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
